Mitsubishi Chemical Holdings

Mitsubishi Tanabe Pharma America and Aquestive Therapeutics Announce U.S. Licensing and Supply Deal for Riluzole Oral Film for ALS Treatment

Retrieved on: 
Thursday, January 21, 2021

"This licensing deal will enable us to bring patients a riluzole oral film designed to address the needs of people with ALS, including those who have difficulties swallowing some medications.

Key Points: 
  • "This licensing deal will enable us to bring patients a riluzole oral film designed to address the needs of people with ALS, including those who have difficulties swallowing some medications.
  • "Mitsubishi Tanabe Pharma America is the right partner for commercializing EXSERVAN oral film formulation of riluzole in the United States."
  • EXSERVAN, anoral film formulation of riluzole, was developed by Aquestive using its PharmFilm innovative drug delivery technology.
  • About Mitsubishi Tanabe Pharma America, Inc.
    Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation's (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc.

Mitsubishi Chemical Advanced Materials Commercializes the World's Strongest Injection Moldable Polymer Compounds

Retrieved on: 
Tuesday, November 10, 2020

MESA, Ariz., Nov. 10, 2020 /PRNewswire/ --As the leading manufacturer of high-performance thermoplastics, Mitsubishi Chemical Advanced Materials, (MCAM) has been perfecting its KyronMAX platform since 2014.

Key Points: 
  • MESA, Ariz., Nov. 10, 2020 /PRNewswire/ --As the leading manufacturer of high-performance thermoplastics, Mitsubishi Chemical Advanced Materials, (MCAM) has been perfecting its KyronMAX platform since 2014.
  • A series of the highest-performance carbon fiber composite materials available today, KyronMAXis the next generation in injection moldable metal replacement technology.
  • Registered trademarks of Mitsubishi Chemical Advanced Materials include: Acetron, CleanStat, Duratron, Ertalyte, Ertalene, Ertalon, Fluorosint, Ketron, Nylatron, Proteus, Sanalite, Semitron, Techtron, KyronMAX and TIVAR.
  • **Mitsubishi Chemical Advanced Materials, formerly Quadrant EPP, was officially named on April 1st, 2019.

Mitsubishi Chemical Advanced Materials Commercializes the World's Strongest Injection Moldable Polymer Compounds

Retrieved on: 
Tuesday, November 10, 2020

MESA, Ariz., Nov. 10, 2020 /PRNewswire/ --As the leading manufacturer of high-performance thermoplastics, Mitsubishi Chemical Advanced Materials, (MCAM) has been perfecting its KyronMAX platform since 2014.

Key Points: 
  • MESA, Ariz., Nov. 10, 2020 /PRNewswire/ --As the leading manufacturer of high-performance thermoplastics, Mitsubishi Chemical Advanced Materials, (MCAM) has been perfecting its KyronMAX platform since 2014.
  • A series of the highest-performance carbon fiber composite materials available today, KyronMAXis the next generation in injection moldable metal replacement technology.
  • Registered trademarks of Mitsubishi Chemical Advanced Materials include: Acetron, CleanStat, Duratron, Ertalyte, Ertalene, Ertalon, Fluorosint, Ketron, Nylatron, Proteus, Sanalite, Semitron, Techtron, KyronMAX and TIVAR.
  • **Mitsubishi Chemical Advanced Materials, formerly Quadrant EPP, was officially named on April 1st, 2019.

Mitsubishi Chemical Advanced Materials is Successful in Carbon Footprint Reduction, While Attaining RC14001:2015® Certification

Retrieved on: 
Wednesday, October 21, 2020

Mitsubishi Chemical Advanced Materials is the first of several Mitsubishi Chemical America (MCA) companies to be certified.

Key Points: 
  • Mitsubishi Chemical Advanced Materials is the first of several Mitsubishi Chemical America (MCA) companies to be certified.
  • James Kohler, Corporate Quality Engineer and North American KAITEKI Coordinator at Mitsubishi Chemical Advanced Materials, says that "Our contributions to KAITEKI take shape in many different forms.
  • Registered trademarks of Mitsubishi Chemical Advanced Materials include: Acetron, CleanStat, Duratron, Ertalyte, Ertalene, Ertalon, Fluorosint, Ketron, Nylatron, Proteus, Sanalite, Semitron, Techtron, KyronMAX and TIVAR.
  • **Mitsubishi Chemical Advanced Materials, formerly Quadrant EPP, was officially named on April 1st, 2019.

Mitsubishi Tanabe Pharma Canada Announces that Saskatchewan Has Added the Company's Treatment for Amyotrophic Lateral Sclerosis (ALS) to its Provincial Drug Plan Formulary

Retrieved on: 
Tuesday, June 30, 2020

TORONTO, June 30, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA (edaravone), an infusion treatment for amyotrophic lateral sclerosis (ALS), is now listed on the Saskatchewan Formulary (special authorization).

Key Points: 
  • TORONTO, June 30, 2020 /CNW/ - Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA), a subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA), announced today that RADICAVA (edaravone), an infusion treatment for amyotrophic lateral sclerosis (ALS), is now listed on the Saskatchewan Formulary (special authorization).
  • About Mitsubishi Tanabe Pharma Canada, Inc.
    Based in Toronto, Mitsubishi Tanabe Pharma Canada, Inc. (MTP-CA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma America, Inc. (MTPA) with a goal to provide therapies for some of the most difficult-to-treat diseases, including ALS.
  • About Mitsubishi Tanabe Pharma America, Inc.
    Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation's (MTPC) 100 percent owned U.S. holding company, Mitsubishi Tanabe Pharma Holdings America, Inc. MTPA is dedicated to delivering innovative products that address the unmet medical needs of patients in North America.
  • October 2019. https://www.mt-pharma-ca.com/our-product/
    SOURCE Mitsubishi Tanabe Pharma Canada, Inc.

EKIMAS Corporation Announces Special Cash Distribution

Retrieved on: 
Monday, April 6, 2020

EKIMAS Corporation (OTCQB: ASNB), formerly AdvanSource Biomaterials Corporation (the Company), which sold substantially all of its assets to Mitsubishi Chemical Performance Polymers, Inc. on January 31, 2020, today announced that the Companys Board of Directors approved a special cash distribution of $0.18 per share at its April 3, 2020 meeting.

Key Points: 
  • EKIMAS Corporation (OTCQB: ASNB), formerly AdvanSource Biomaterials Corporation (the Company), which sold substantially all of its assets to Mitsubishi Chemical Performance Polymers, Inc. on January 31, 2020, today announced that the Companys Board of Directors approved a special cash distribution of $0.18 per share at its April 3, 2020 meeting.
  • The cash distribution is payable on April 23, 2020 to shareholders of record as of April 16, 2020.
  • EKIMAS Corporation, formerly AdvanSource Biomaterials Corporation (the Company), sold substantially all of its assets to Mitsubishi Chemical Performance Polymers, Inc. on January 31, 2020 (the Closing Date).
  • As a result, the Company ceased operating as a manufacturer and seller of advanced polymers.

AdvanSource Biomaterials Corporation Announces Completion of the Sale of Substantially All of its Assets to a Subsidiary of Mitsubishi Chemical America

Retrieved on: 
Monday, February 3, 2020

As previously announced, AdvanSource entered into an Asset Purchase Agreement with MCPP, a subsidiary of Mitsubishi Chemical America, Inc. and its shareholder, Mitsubishi Chemical Corporation, to sell substantially all of its assets to Mitsubishi Chemical Performance Polymers for a price of $7.25 million in cash (the Transaction).

Key Points: 
  • As previously announced, AdvanSource entered into an Asset Purchase Agreement with MCPP, a subsidiary of Mitsubishi Chemical America, Inc. and its shareholder, Mitsubishi Chemical Corporation, to sell substantially all of its assets to Mitsubishi Chemical Performance Polymers for a price of $7.25 million in cash (the Transaction).
  • The successful completion of this transaction offers our shareholders a meaningful premium, said Michael Adams, CEO of AdvanSource.
  • Its biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states.
  • Mitsubishi Chemical Performance Polymers, Inc. is a specialty chemical company and direct subsidiary of Mitsubishi Chemical America, Inc., the regional headquarters in North America of Mitsubishi Chemical Corporation.

AdvanSource Biomaterials Corporation Enters Into a Definitive Agreement to Sell Substantially All of Its Assets to a Subsidiary of Mitsubishi Chemical America

Retrieved on: 
Monday, November 25, 2019

The Transaction has been approved by the Board of Directors of both companies and is not subject to any financing conditions.

Key Points: 
  • The Transaction has been approved by the Board of Directors of both companies and is not subject to any financing conditions.
  • Its biomaterials are used in devices that are designed for treating a broad range of anatomical sites and disease states.
  • Mitsubishi Chemical Performance Polymers, Inc. is a specialty chemical company and direct subsidiary of Mitsubishi Chemical America, Inc., the regional headquarters in North America of Mitsubishi Chemical Corporation.
  • AdvanSource undertakes and assumes no obligation, and does not intend, to update AdvanSource's forward-looking statements, except as required by law.

Mitsubishi Chemical Composites America Names New Regional Sales Managers

Retrieved on: 
Tuesday, October 29, 2019

CHESAPEAKE, Va., Oct. 29, 2019 /PRNewswire/ -- Mitsubishi Chemical Composites America (MCCA), a leader in metal composite materials manufacturing, is proud to announce the addition of three, new Regional Sales Managers for its ALPOLIC line of business.

Key Points: 
  • CHESAPEAKE, Va., Oct. 29, 2019 /PRNewswire/ -- Mitsubishi Chemical Composites America (MCCA), a leader in metal composite materials manufacturing, is proud to announce the addition of three, new Regional Sales Managers for its ALPOLIC line of business.
  • In the reorganized Southwest Region, MCCA added two new Regional Managers, Rigo Vega who will oversee Southern California and Marc Ellis who will manage Northern California.
  • As Regional Sales Managers, all will oversee established client accounts, while continuing to promote ALPOLIC to the area's numerous architects, fabricators, designers and specifiers.
  • Our Chesapeake, Virginia facility began production in 1991 and is home to Mitsubishi Chemical Composites America.

Mitsubishi Chemical Advanced Materials Brings Innovative Plastic & Polymer Materials to SEMICON West 2019

Retrieved on: 
Wednesday, July 3, 2019

SAN FRANCISCO, July 3, 2019 /PRNewswire-PRWeb/ -- Mitsubishi Chemical Advanced Materials, leading global supplier of high-performance thermoplastics, will be on hand at SEMICON West 2019 this July to showcase their innovative Engineering Plastic Materials for the Semiconductor and Electronics industries.

Key Points: 
  • SAN FRANCISCO, July 3, 2019 /PRNewswire-PRWeb/ -- Mitsubishi Chemical Advanced Materials, leading global supplier of high-performance thermoplastics, will be on hand at SEMICON West 2019 this July to showcase their innovative Engineering Plastic Materials for the Semiconductor and Electronics industries.
  • Mitsubishi Chemical Advanced Materials' recent focus is on providing cost savings through the usage of proprietary Near Net Shape manufacturing.
  • Learn more about Mitsubishi Chemical Advanced Materials innovative family of products at SEMICON West 2019 (booth # 339) at the Moscone Center in San Francisco, CA from July 9 - 11, 2019.
  • Learn more about Mitsubishi Chemical Advanced Materials at mcam.com or connect with Mitsubishi Chemical Advanced Materials on Facebook , LinkedIn , and Twitter.